Following expert hematopathology review, reclassification rates approached one third (AITL, PTCL-NOS) to one half (ALK-negative ALCL) for certain subtypes of PTCL [84]. Here, ALK is linked to mature T-cell and NK-cell non-Hodgkin lymphoma.